[1]邵敬芝,彭广华.干细胞移植治疗视网膜变性疾病的研究进展[J].眼科新进展,2016,36(2):181-185.[doi:10.13389/j.cnki.rao.2016.0050]
　SHAO Jing-Zhi,PENG Guang-Hua.Advances in stem cell transplantation for retinal degeneration[J].Recent Advances in Ophthalmology,2016,36(2):181-185.[doi:10.13389/j.cnki.rao.2016.0050]
点击复制

干细胞移植治疗视网膜变性疾病的研究进展
分享到：

《眼科新进展》[ISSN:1003-5141/CN:41-1105/R]

卷:
36卷
期数:
2016年2期
页码:
181-185
栏目:
文献综述
出版日期:
2016-02-05

文章信息/Info

Title:
Advances in stem cell transplantation for retinal degeneration
作者:
邵敬芝; 彭广华
450052　河南省郑州市，郑州大学第一附属医院眼科
Author(s):
SHAO Jing-Zhi;  PENG Guang-Hua
Department of Ophthalmology, the First Affiliated Hospital of Zhengzhou University , Zhengzhou 450052 . Henan Province . China
关键词:
视网膜变性疾病; 视网膜干细胞; 胚胎干细胞; 诱导多潜能干细胞
Keywords:
retinal degeneration disease ;  retinal stem cell;  embryonic stem cell;  induced pluripotent stem cell
DOI:
10.13389/j.cnki.rao.2016.0050
文献标志码:
A
摘要:
视网膜变性疾病是一类与遗传相关的变性疾病，导致患者渐进性视觉丢失，是主要的致盲性眼病之一，其共同病理基础是视网膜光感受器细胞的变性、坏死和凋亡，然而目前尚无有效的治疗方法。细胞移植治疗是目前实验研究治疗视网膜变性疾病的主要方法之一。近年研究表明将感光前体细胞或视网膜色素上皮细胞移植到视网膜下腔或玻璃体内，可以延缓宿主感光细胞的凋亡、替代凋亡的感光细胞、挽救残存的视觉功能和修复视网膜结构。细胞移植治疗的一个很重要的问题是移植细胞的来源问题，目前主要的移植细胞来源是视网膜祖／干细胞、胚胎干细胞和诱导多潜能干细胞等。本文就干细胞移植治疗视网膜变性疾病的研究进展进行综述。
Abstract:
Retinal degeneration diseases leading to the loss of the light sensitive photoreceptors are a major cause of untreatable blindness in the world. These diseases culminate in the same final common pathway , the degeneration , necrosis and apoptosis of the light-sensing photoreceptors , which causes severe or complete loss of vision. Nevertheless .there are few effective treatments to the diseases. Cell replacement therapy is one of the most promising treatment methods. Recent researches show that photoreceptor precursor cells or retinal pigmented epithelial cells . which can be transplanted into the subretinal space or vitreous , have the capacity to inhibit apoptosis of photoreceptor cells ,repair the retinal structure and restore some visual function. However, one of the most important problems is the resource of the replacement cells. Nowadays , the main resource of the replacement cells are retinal stem cells , embryonic stem cells . induced pluripotent stem cells . etc. This article reviews the recent advances in stem cells transplantation for retinal degeneration diseases.

相似文献/References:

[1]李岩,贺新征,李军,等.睫状缘色素细胞与骨髓间充质干细胞体外共培养构建视网膜干细胞的初步研究[J].眼科新进展,2016,36(1):019.[doi:10.13389/j.cnki.rao.2016.0006]
　LI Yan,HE Xin-Zheng,LI Jun,et al.Preliminary study of retinal stem cells fabrication by direct co-culture of ciliary margin pigment cells and bone marrow mesenchymal stem cells[J].Recent Advances in Ophthalmology,2016,36(2):019.[doi:10.13389/j.cnki.rao.2016.0006]
[2]戴敏,张青,郑志坤,等.视网膜神经节细胞无血清上清培养液诱导大鼠视网膜干细胞的分化[J].眼科新进展,2018,38(1):035.[doi:10.13389/j.cnki.rao.2018.0007]
　DAI Min,ZHANG Qing,ZHENG Zhi-Kun,et al.Retinal ganglion cell-conditioned medium alters the differentiation of rat retinal progenitor cells[J].Recent Advances in Ophthalmology,2018,38(2):035.[doi:10.13389/j.cnki.rao.2018.0007]
[3]祁玉麟,叶河江.嘌呤P2X7受体在视网膜变性类疾病中的作用研究进展[J].眼科新进展,2022,42(4):323.[doi:10.13389/j.cnki.rao.2022.0065]
　QI Yulin,YE Hejiang.Advances in the role of purinergic ligand-gated ion channel 7 receptor in retinal degenerative diseases[J].Recent Advances in Ophthalmology,2022,42(2):323.[doi:10.13389/j.cnki.rao.2022.0065]

备注/Memo

备注/Memo:
国家重点基础研究发展计划（编号：２０１３ＣＢ９６７００１）；国家自然科学基金项目（编号： ３１２７１４００、３１４７００６５）
更新日期/Last Update: 2016-01-29